☆ 4.8 Meeting Abstract

Docetaxel-induced mucositis in breast cancer patients: Association with plasma alpha-1-acid glycoprotein level and SLCO1B3 genotype

CANCER RESEARCH (2014)

Journal

CANCER RESEARCH

Volume 74, Issue 19, Pages -

Publisher

AMER ASSOC CANCER RESEARCH

DOI: 10.1158/1538-7445.AM2014-5563

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes

Alessandro Mantovani, Alessandro Csermely, Elena Sani, Giorgia Beatrice, Graziana Petracca, Gianluigi Lunardi, Stefano Bonapace, Giuseppe Lippi, Giovanni Targher

Summary: This study examined the association between plasma LRG1 levels and specific plasma ceramides in postmenopausal women with T2DM, showing that higher plasma LRG1 concentration was associated with higher levels of specific high-risk plasma ceramides.

BIOMOLECULES (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Biomolecular Corona Stability in Association with Plasma Cholesterol Level

Duong N. Trinh, Meda Radlinskaite, Jack Cheeseman, Gunter Kuhnle, Helen M. Osborn, Paula Meleady, Daniel I. R. Spencer, Marco P. Monopoli

Summary: Biomolecular corona spontaneously forms on the surface of nanoparticles in contact with biological fluids, playing a crucial role in their colloidal stability and toxicity assessment. This study reveals a strong correlation between the colloidal stability of nanoparticles and the level of cholesterol in human plasma, primarily due to the enrichment of high-density lipoprotein (HDL) and low-density lipoprotein (LDL) in the biomolecular corona.

NANOMATERIALS (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

Characterization of alpha-1-acid glycoprotein as a potential biomarker for breast cancer

Luo Qiong, Jun Yin

Summary: Breast cancer is a serious threat to women's health worldwide, and its early diagnosis remains challenging. This study found that AGP expression is high in breast cancer cells and tissues, making it a potential diagnostic biomarker and therapeutic target for breast cancer.

BIOENGINEERED (2022)

Add to Collection

Article Oncology

Glycoprotein hormone alpha-subunit promotes cell proliferation and tumorigenesis in breast cancer

Jun Zhou, Xuan Zhu, Shijie Wu, Huihui Chen, Yiding Chen

Summary: This study found that increased expression of CGA in breast cancer is associated with a poor prognosis. CGA enhances breast cancer cell proliferation by activating signaling cascades, such as epidermal growth factor receptor. These results suggest that CGA may serve as a candidate for developing targeted therapies for breast cancer.

ONCOLOGY LETTERS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease

Chen-Chih Chung, Lung Chan, Jia-Hung Chen, Yi-Chieh Hung, Chien-Tai Hong

Summary: Plasma extracellular vesicle (EV) alpha-synuclein levels were significantly lower in patients with Parkinson's disease (PD) compared to controls, and were associated with the severity of akinetic-rigidity symptoms in PD patients. This study supports the diagnostic potential and clinical relevance of plasma EV alpha-synuclein as a biomarker for PD subtyping.

BIOMOLECULES (2021)

Add to Collection

Letter Medicine, General & Internal

Association of Pertuzumab, Trastuzumab, and Docetaxel Combination Therapy With Overall Survival in Patients With Metastatic Breast Cancer

Sreeram V. Ramagopalan, Riccardo Pisoni, Lokendra Singh Rathore, Joshua Ray, Cormac Sammon

Summary: This cohort study compares the efficacy of combined pertuzumab, trastuzumab, and docetaxel therapy in women with metastatic breast cancer with the results of the CLEOPATRA trial.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Oncology

Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial

Andrea DeCensi, Harriet Johansson, Thomas Helland, Matteo Puntoni, Debora Macis, Valentina Aristarco, Silvia Caviglia, Tania Buttiron Webber, Irene Maria Briata, Mauro D'Amico, Davide Serrano, Aliana Guerrieri-Gonzaga, Ersilia Bifulco, Steinar Hustad, Havard Soiland, Luca Boni, Bernardo Bonanni, Gunnar Mellgren

Summary: Low-dose tamoxifen can reduce the risk of recurrence in non-invasive breast cancer by half without significant adverse events. Most subjects treated with 5 mg/day have endoxifen levels below 9 nM, and there is no significant association with recurrence, indicating that tamoxifen failure is not related to poor drug metabolism.

NPJ BREAST CANCER (2021)

Add to Collection

Article Cell Biology

lncSNHG3 drives breast cancer progression by epigenetically increasing CSNK2A1 expression level

Zhenlin Nie, Mu Xu, Linpeng Zhou, Bei Pan, Tao Xu, Bangshun He, Shukui Wang

Summary: Mounting evidence shows the critical role of long noncoding RNAs (lncRNAs) in cancer initiation and progression. This study reveals that small nucleolar RNA host gene 3 (SNHG3) acts as a key regulator of breast cancer progression. Through various assays and experiments, the study demonstrates that SNHG3 is upregulated in breast cancer tissues and its high expression is associated with poor survival. The study also uncovers the mechanism of SNHG3 action and its involvement in the malignant progression of breast cancer.

AGING-US (2023)

Add to Collection

Article Oncology

Association of plasma docetaxel levels with ABCB1 gene polymorphisms and tumour response in locally advanced breast cancer patients of South India on neo-adjuvant chemotherapy

Rekha Priyadarshini, Gerard Marshall Raj, Rajan Sundaram, Smita Kayal, Ananthakrishnan Ramesh, Deepak Gopal Shewade

Summary: This study demonstrated a significant association between SNP rs1128503 (C1236T) in the ABCB1 gene and plasma levels of docetaxel, while SNP rs1045642 (C3435T) showed no association. Patients with higher plasma levels of docetaxel had better tumor response.

BREAST CANCER (2021)

Add to Collection

Article Cell Biology

Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-alpha-TAK1-MMP9 axis

Eun-Gene Sun, Veena Vijayan, Mi-Ra Park, Kyung Hyun Yoo, Sang-Hee Cho, Woo-Kyun Bae, Hyun-Jeong Shim, Jun-Eul Hwang, In-Kyu Park, Ik-Joo Chung

Summary: Transforming growth factor-beta-activated kinase 1 (TAK1) plays a key role in metastasis and progression of triple-negative breast cancer (TNBC). This study investigates the role of lectin galactoside-binding soluble 3 binding protein (LGALS3BP) and its interaction with TAK1 in TNBC. The results show that LGALS3BP inhibits TNF-alpha-mediated activation of TAK1 and suppresses TNBC progression. Nanoparticle-mediated delivery of LGALS3BP targets tumor tissues and inhibits TAK1 phosphorylation, thus suppressing primary tumor growth and lung metastasis in TNBC.

CELL DEATH DISCOVERY (2023)

Add to Collection

Article Chemistry, Analytical

Quantitative detection of α1-acid glycoprotein (AGP) level in blood plasma using SERS and CNN transfer learning approach

M. Erzina, A. Trelin, O. Guselnikova, A. Skvortsova, K. Strnadova, V. Svorcik, O. Lyutakov

Summary: In this study, a combination of functional SERS substrate and CNN transfer learning was proposed for quantitative detection of a specific biomolecule in human serum. The method allows for quick and decentralized identification of increased biomolecule concentration, making it a valuable tool for analysis in the absence of spectral data.

SENSORS AND ACTUATORS B-CHEMICAL (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Physiologically Based Pharmacokinetic Model of Brain Delivery of Plasma Protein Bound Drugs

William M. M. Pardridge

Summary: A physiologically based pharmacokinetic (PBPK) model was developed to study drug association and dissociation with plasma proteins and brain tissue proteins, as well as drug permeability at the blood-brain barrier. The model evaluated the impact of plasma protein-mediated uptake on the concentration of free drug in the brain and studied the effect of drug binding to brain tissue proteins on free drug concentration in the brain.

PHARMACEUTICAL RESEARCH (2023)

Add to Collection

Article Nutrition & Dietetics

The association of dietary and plasma fatty acid composition with FTO gene expression in human visceral and subcutaneous adipose tissues

Emad Yuzbashian, Golaleh Asghari, Catherine B. Chan, Mehdi Hedayati, Mohammad Safarian, Maryam Zarkesh, Parvin Mirmiran, Alireza Khalaj

Summary: This study found that dietary intake of total fatty acids, MUFA, and PUFA were positively associated with FTO gene expression in both subcutaneous and visceral adipose tissues. There were no associations between plasma fatty acids and FTO mRNA expression in either adipose tissues.

EUROPEAN JOURNAL OF NUTRITION (2021)

Add to Collection

Article Genetics & Heredity

Evaluation of the Association between FGFR2 Gene Polymorphisms and Breast Cancer Risk in the Bangladeshi Population

Nusrat Jahan, Mobashera Begum, Md Abdul Barek, Md. Abdul Aziz, Md. Shafiul Hossen, Khokon Kanti Bhowmik, Tahmina Akter, Md. Rabiul Islam, Hadi Sajid Abdulabbas, Mohammad Safiqul Islam

Summary: Breast cancer is the leading cause of cancer-related deaths in women. Variants of the FGFR2 gene have been found to be strongly associated with breast cancer risk. This study investigated the association between FGFR2 gene polymorphisms and breast cancer in a Bangladeshi population. The findings showed significant associations between certain FGFR2 variants (rs1219648 and rs2981582) and breast malignancy risk.

GENES (2023)

Add to Collection

Article Pediatrics

Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development

Sherry Zhao, Mary Gockenbach, Manuela Grimstein, Hari Cheryl Sachs, Mark Mirochnick, Kimberly Struble, Yodit Belew, Jian Wang, Edmund Capparelli, Brookie M. Best, Tamara Johnson, Jeremiah D. Momper, Anil R. Maharaj

Summary: The study quantitatively described the time-course of albumin and a1-acid glycoprotein concentrations in pregnant and postpartum women living with HIV. It found that albumin concentrations remained stable during pregnancy and increased postpartum, while AAG concentrations slightly decreased during pregnancy and increased postpartum.

FRONTIERS IN PEDIATRICS (2021)

Add to Collection

Meeting Abstract Oncology

Final survival analysis of a phase 3 study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2-positive early or locally advanced breast cancer

Xavier Pivot, Mark D. Pegram, Javier Cortes, Diana Luftner, Gary H. Lyman, Giuseppe Curigliano, Igor M. Bondarenko, Mikhail Dvorkin, Jin Hee Ahn, Seock-Ah Im, Maria Litwiniuk, Yaroslav V. Shparyk, Gwo Fuang Ho, Nikolay V. Kislov, Marek Wojtukiewicz, Tomasz Sarosiek, Yee Soo Chae, Jin Seok Ahn, Hyerin Jang, Sujung Kim, Jiwon Lee, Soo Young Lee, Ye Chan Yoon

CANCER RESEARCH (2022)

Add to Collection

Review Chemistry, Medicinal

Pharmacological Modulation of Apoptosis and Autophagy in Pancreatic Cancer Treatment

Nityaa Selvarajoo, Johnson Stanslas, Mohammad Kaisarul Islam, Sreenivasa Rao Sagineedu, Ho Kok Lian, Jonathan Chee Woei Lim

Summary: This review summarizes the regulatory mechanisms of apoptosis and autophagy in pancreatic cancer and the potential drug-like molecules that target these pathways. By targeting apoptosis and autophagy, the effectiveness of pancreatic cancer treatment can be improved. Several drugs have shown synergistic effects when combined with chemotherapy.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Oncology

Programmed death-ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non-small-cell lung cancer in a resource-limited country

Soon Hin How, Lye Mun Tho, Chong Kin Liam, Harissa H. Hasbullah, Gwo Fuang Ho, Ibtisam Muhammad Nor, Mau Ern Poh, Kean Fatt Ho, Muthukkumaran Thiagarajan, Azlina Samsudin, Azza Omar, Choo Khoon Ong, Yong Kek Pang, Sing Yang Soon

Summary: This study presents the first analysis of PD-L1 expression and ICI use in Malaysia. Despite the proven efficacy of ICI therapy, only a small percentage of patients underwent PD-L1 testing and a limited number of eligible patients received ICI treatment.

THORACIC CANCER (2022)

Add to Collection

Review Plant Sciences

Revisiting Trigonella foenum-graecum L.: Pharmacology and Therapeutic Potentialities

Theysshana Visuvanathan, Leslie Thian Lung Than, Johnson Stanslas, Shu Yih Chew, Shalini Vellasamy

Summary: Fenugreek is a medicinal plant with therapeutic characteristics that has been utilized since ancient times. It contains various secondary metabolites which have been shown to have therapeutic effects through animal and clinical studies. Fenugreek has the potential to be used as a credible medicinal plant for deriving new drugs.

PLANTS-BASEL (2022)

Add to Collection

Article Chemistry, Medicinal

Mapping Molecular Networks within Clitoria ternatea Linn. against LPS-Induced Neuroinflammation in Microglial Cells, with Molecular Docking and In Vivo Toxicity Assessment in Zebrafish

Nurul Farah Adni Mat Zian, Puspanjali Swain, Siti Munirah Mohd Faudzi, Norzalina Zakaria, Wan Norhamidah Wan Ibrahim, Noraini Abu Bakar, Khozirah Shaari, Johnson Stanslas, Tae-Ik Choi, Cheol-Hee Kim

Summary: In this study, the ethyl acetate fraction of butterfly pea flower was analyzed and found to have neuroprotective and anti-neuroinflammatory properties. The metabolome analysis identified flavonol 3-O-glycosides, hydrocinnamic acids, and primary metabolites as potential bioactive compounds. Molecular docking studies suggested that the fraction targets iNOS and decreases nitric oxide levels. In vivo toxicity tests in zebrafish models showed no harmful effects on development, blood vessel formation, and apoptosis. These preliminary findings provide scientific support for the anti-neuroinflammatory and neuroprotective effects of butterfly pea.

PHARMACEUTICALS (2022)

Add to Collection

Article Oncology

Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia

Soon Hin How, Chong Kin Liam, Muhammad Adil Zainal Abidin, Harissa H. Hasbullah, Lye Mun Tho, Gwo Fuang Ho, Ibtisam Muhamad Nor, Yong Kek Pang, Kean Fatt Ho, Muthukkumaran Thiagarajan, Roziana Ariffin, Azlina Samsudin, Azza Omar, Sin Nee Tan, Choo Khoon Ong, Sing Yang Soon, Mau Ern Poh

Summary: This study describes the management and outcomes of EGFRm+ advanced NSCLC patients in an Asian cost-restrictive setting. The results suggest that the choice of first-line therapy, time on each line of treatment, and subsequent treatment options may adversely affect the overall survival of patients.

CANCER MANAGEMENT AND RESEARCH (2022)

Add to Collection

Article Psychology, Multidisciplinary

Adverse events following immunization and psychological distress among cancer patients/survivors following vaccination against SARS-CoV-2 infection

Li Ping Wong, Lee Lee Lai, Mee Hoong See, Haridah Alias, Sharifah Faridah Syed Omar, Chong Guan Ng, Gwo Fuang Ho, Teng Aik Ong, Yee Chi Wong, Po Lin Ooi, Jasmin Munchar Elias, Zhijian Hu, Yulan Lin

Summary: This study describes the adverse events following SARS-CoV-2 vaccination in cancer patients/survivors and their psychological distress. The results show that anxiety and depression scores significantly decreased after vaccination. Most participants experienced mild-to-moderate systemic and local adverse events, with pain at the injection site, tiredness, and headache being the most common symptoms. The study also found a positive correlation between the severity of adverse events and anxiety and depressive symptoms.

FRONTIERS IN PSYCHOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

The impact of cycleanine in cancer research: a computational study

Ogochukwu Ngozi Nwaefulu, Nizar A. Al-Shar'i, Josephine Omonkhelin Owolabi, Sreenivasa Rao Sagineedu, Lim Chee Woei, Lam Kok Wai, Mohammad Kaisarul Islam, Sivaraman Jayanthi, Johnson Stanslas

Summary: This study investigated the cytotoxic activity of cycleanine and found that it may function as an inhibitor of the PARP1 enzyme. The results of this research are important for the development of new anti-cancer drugs.

JOURNAL OF MOLECULAR MODELING (2022)

Add to Collection

Review Oncology

Safe and effective treatment of venous Thromboembolism associated with Cancer: focus on direct Oral Anticoagulants in Asian patients

Lai Heng Lee, Pongwut Danchaivijitr, Noppacharn Uaprasert, Harinder Gill, Dennis Lee Sacdalan, Gwo Fuang Ho, Rajiv Parakh, Paresh Pai, Jen-Kuang Lee, Nannette Rey, Alexander T. Cohen

Summary: Direct oral anticoagulants (DOACs) have shown comparable efficacy and safety outcomes in Asian patients with cancer-associated thrombosis (CAT) compared to other races. Apixaban, edoxaban, or rivaroxaban can be considered as reasonable alternatives to low-molecular-weight heparin (LMWH) for anticoagulation in Asian patients with CAT.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2022)

Add to Collection

Article Oncology

Cancer-related costs, the resulting financial impact and coping strategies among cancer survivors living in a setting with a pluralistic health system: a qualitative study

Noorulain Fnu, Wai-Chee Kuan, Yek-Ching Kong, Ros Suzanna Bustamam, Li-Ping Wong, ShriDevi Subramaniam, Gwo-Fuang Ho, Hafizah Zaharah, Cheng-Har Yip, Nirmala Bhoo-Pathy

Summary: Limited evidence exists on the financial experiences of cancer survivors in Malaysia. This study explored the out-of-pocket costs, financial impact, and coping strategies of cancer survivors in Malaysia's pluralistic health system. The study found that cancer therapies, supportive care, complementary therapies, non-medical costs, and loss of household income were major themes related to cancer costs. Coping mechanisms included changing treatment decisions, continuing work despite illness, and seeking financial assistance from third parties.

ECANCERMEDICALSCIENCE (2022)

Add to Collection

Review Oncology

Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?

Amir Imran Faisal Hamdi, Soon Hin How, Mohammad Kaisarul Islam, Jonathan Chee Woei Lim, Johnson Stanslas

Summary: The article discusses the improved understanding of drug resistance in cancer and the debate between continuous therapy, intermittent clinical regimens, and adaptive therapy. It provides insights into how adaptive therapy can suppress the growth of drug resistance and offer safe treatment for cancer patients in the future.

EXPERT REVIEW OF ANTICANCER THERAPY (2022)

Add to Collection

Article Oncology

Real-World Treatment and Outcomes of ALK-Positive Metastatic Non-Small Cell Lung Cancer in a Southeast Asian Country

Mau Ern Poh, Soon Hin How, Gwo Fuang Ho, Yong Kek Pang, Harissa H. Hasbullah, Lye Mun Tho, Ibtisam Muhamad Nor, Bee Chiu Lim, Kean Fatt Ho, Muthukkumaran Thiagarajan, Azlina Samsudin, Azza Omar, Choo Khoon Ong, Sing Yang Soon, Justin Yu Kuan Tan, Muhammad Adil Zainal Abidin

Summary: This study examined the treatment patterns and clinical outcomes of ALK-positive NSCLC in Malaysia using data from a nationwide lung cancer registry. The results showed that patients on ALK inhibitors had better overall survival and longer time on treatment compared to chemotherapy, suggesting long-term benefits of ALK inhibitors.

CANCER MANAGEMENT AND RESEARCH (2023)

Add to Collection

Article Oncology

Challenges and Strategies for Improving Access to Cancer Drugs in Malaysia: Summary of Opinions Expressed at the 2nd MACR International Scientific Conference 2022

Shing Cheng Tan, Wen Tsin Poh, Audrey Chee Hui Yong, Eng Wee Chua, Der Jiun Ooi, Rozi Mahmud, Muthukkumaran Thiagarajan, Johnson Stanslas

Summary: Considerable progress has been made in cancer drug development in recent decades. However, many of these drugs are not readily available in low- and middle-income countries like Malaysia. This paper presents the results of a forum discussion held during a scientific conference, addressing challenges to cancer drug access in Malaysia and proposing strategies for improvement, including cost reduction mechanisms, uptake of biosimilars and generics, and local manufacturing.

CANCER MANAGEMENT AND RESEARCH (2023)

Add to Collection

Article Oncology

More than just a KRAS inhibitor: DCAI abrogates the self-renewal of pancreatic cancer stem cells in vitro

Yuan Han Teh, Rui Jing, Rajesh Ramasamy, Kok Lian Ho, Sreenivasa Rao Sagineedu, Johnson Stanslas

Summary: DCAI inhibits self-renewal of pancreatic CSCs via KRAS-CRAF-ERK1/2-SOX2 and KRAS-AKT-SOX2 axes.

ONCOLOGIE (2023)

Add to Collection

Meeting Abstract Oncology

A phase II, single-arm, open label, Simon two-stage study of pembrolizumab in patients with metastatic HER2-negative breast cancer: Evaluation of impact of germline variants in APOBEC3B (AUROR).

Gwo Fuang Ho, Soo-Chin Lee, Joanna Lim, Anita Zarina Bustam, Siew Eng Lim, Marniza Saad, Samuel Guan Wei Ow, Natalie Ngoi, Nur Fadhlina Abdul Satar, Rozita Abdul Malik, Adlinda Alip, Kian Boon Law, Yok Yong Toh, Jia Wern Pan, Soo Hwang Teo

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.